Skip to main content
main-content

Prediabetes and prevention

Medications

05-02-2019 | Cardiovascular disorders | News

Metformin may be cardioprotective in patients with coronary artery disease

Findings from the MET-REMODEL trial suggest that metformin treatment may aid regression of left ventricular hypertrophy among nondiabetic patients with coronary artery disease.

04-23-2019 | Metformin | News

Metformin may help people at high diabetes risk to maintain weight loss

Fifteen years of follow-up of the DPP trial shows that although people initially lost more weight with the intensive lifestyle intervention, those assigned to metformin did better at keeping the weight off in the long term.

10-09-2018 | Children | EASD 2018 | News

RISE pediatric findings consistent over longer term

The RISE investigators have reported a continued lack of effect of early intensive therapy on beta-cell function decline in children with prediabetes or early type 2 diabetes.

10-05-2018 | Lorcaserin | EASD 2018 | News

Weight loss with lorcaserin linked to improved glycemic profile

Losing weight in the CAMELLIA-TIMI 61 trial was associated with a significantly reduced risk for developing type 2 diabetes, the investigators have reported at the 54th EASD Annual Meeting in Berlin, Germany.

09-17-2018 | Prediabetes | medwireNews | News

Targeting pathophysiology from outset may slow progression to type 2 diabetes

Upfront treatment with medications that target the underlying pathophysiology of prediabetes may slow patients’ progression to type 2 diabetes, report researchers.

06-24-2018 | Prediabetes | ADA 2018 | News

Shared decision-making enhances prevention efforts in prediabetes

A pharmacist-led shared decision-making intervention significantly increases the uptake of lifestyle-change programs and metformin use in patients with prediabetes, results of the PRIDE study show.

06-23-2018 | Diabetes prevention | Review | Article

2020 vision: An overview of prospects for diabetes management and prevention in the next decade

Wang CY, Neil DL, Home P. Diabetes Res Clin Prac 2018; 143: 101–112. doi: 10.1016/j.diabres.2018.06.007

06-22-2018 | Monogenic diabetes | Review | Article

Advances in the genetics of youth-onset type 2 diabetes

Todd JN, Srinivasan S, Pollin TI. Curr Diab Rep 2018; 18: 57. doi: 10.1007/s11892-018-1025-1

06-16-2018 | Risk factors | Review | Article

Methods for measuring risk for type 2 diabetes in youth: The oral glucose tolerance test (OGTT)

Chen ME, Aguirre RS, Hannon TS. Curr Diab Rep 2018; 18: 51. doi: 10.1007/s11892-018-1023-3

06-15-2018 | Diet | Article

Association between dietary protein intake and type 2 diabetes varies by dietary pattern

Ke Q et al. Diabetol Metab Syndr 2018; 10: 48. doi: 10.1186/s13098-018-0350-5

06-08-2018 | Insulin resistance | Review | Article

Chronic kidney disease-induced insulin resistance: Current state of the field

Dave N, Wu J, Thomas S. Curr Diab Rep 2018; 18: 44. doi: 10.1007/s11892-018-1010-8

06-06-2018 | Mental health | Article

The relationship between sleep and cognitive function in patients with prediabetes and type 2 diabetes

Saetung S et al. Acta Diabetol 2018. doi: 10.1007/s00592-018-1166-3

06-04-2018 | Pediatrics | Review | Article

Identifying prediabetes and type 2 diabetes in asymptomatic youth: Should HbA1c be used as a diagnostic approach?

Vajravelu ME, Lee JM. Curr Diab Rep 2018; 18: 43. doi: 10.1007/s11892-018-1012-6

05-19-2018 | Risk factors | Review | Article

Prioritising risk factors for type 2 diabetes: Causal inference through genetic approaches

Wittemans LBL, Lotta LA, Langenberg C. Curr Diab Rep 2018; 18: 40. doi: 10.1007/s11892-018-1009-1

05-18-2018 | Gestational diabetes | Review | Article

Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetes

Yeung RO et al. Rev Endocr Metab Disord 2018. doi: 10.1007/s11154-018-9446-3

05-09-2018 | Diagnosis | Case study | Article

Atypical diabetes: Case study 4

Can you diagnose the atypical form of diabetes presented in our fourth patient case study? Test your knowledge with Editorial Board member, Jay Shubrook.

05-05-2018 | Physical activity | Review | Article

May the force be with you: Why resistance training is essential for subjects with type 2 diabetes mellitus without complications

Codella R et al. Endocrine 2018; Advance online publication. doi: 10.1007/s12020-018-1603-7

05-04-2018 | GLP-1 agonists | Review | Article

Glucagon-like peptide 1 in health and disease

Andersen A et al. Nat Rev Endocrinol 2018; Advance online publication. doi: 10.1038/s41574-018-0016-2

image credits